Blood Based Biomarkers Predicting Memory Loss episode artwork

EPISODE · Aug 6, 2026 · 1H 4M

Blood Based Biomarkers Predicting Memory Loss

from The Longevity Podcast: Optimizing HealthSpan & MindSpan · host Dung Trinh

Send us Fan MailImagine learning that your brain is on a specific trajectory toward memory loss and you find out from a routine blood draw, not a spinal tap, not a hard-to-access PET scan. That future is arriving fast, and it’s creating a new challenge: we don’t have one “Alzheimer’s blood test” anymore. We have a growing menu of brain biomarkers, each reporting on a different kind of cellular crisis, and the only way to use them well is to match the marker to the underlying biology.We walk through four of the biggest names in blood-based dementia diagnostics and brain health monitoring: p-tau217, p-tau181, NFL (neurofilament light chain), and GFAP. You’ll learn what each protein normally does, what it means when it shows up in plasma, and how ultrasensitive Simoa technology can measure these signals at almost unimaginable concentrations. Then we dig into a rigorous 2026 study that compares two very different cohorts, a South Korean memory clinic group and the North American ADNI research cohort, to test whether these biomarkers hold up across demographics, education levels, and disease stages.The headline finding is a true plot twist: amyloid status flips the winners. In amyloid-positive people, p-tau217 emerges as the strongest predictor of cognitive decline, while GFAP can be a dominant signal for brain atrophy in symptomatic patients. In amyloid-negative people, NFL becomes the most reliable indicator of neurodegeneration and overall cognitive worsening, pointing to non-Alzheimer’s causes where general axonal injury is the key story. If you care about early Alzheimer’s detection, precision neurology, or the future of dementia screening, this is the framework to know. Subscribe, share this with someone navigating memory concerns, and leave a review with the biomarker question you want answered next.This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice. Never miss an episode—subscribe on your favorite podcast app!

Episode metadata supplied by the publisher feed · Published Aug 6, 2026

Embed this episode

Send us Fan Mail Imagine learning that your brain is on a specific trajectory toward memory loss and you find out from a routine blood draw, not a spinal tap, not a hard-to-access PET scan. That future is arriving fast, and it’s creating a new challenge: we don’t have one “Alzheimer’s blood test” anymore. We have a growing menu of brain biomarkers, each reporting on a different kind of cellular crisis, and the only way to use them well is to match the marker to the underlying biology. We wal...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Blood Based Biomarkers Predicting Memory Loss

0:00 1:04:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Longevity Podcast: Optimizing HealthSpan & MindSpan?

This episode is 1 hour and 4 minutes long.

When was this The Longevity Podcast: Optimizing HealthSpan & MindSpan episode published?

This episode was published on August 6, 2026.

Can I download this The Longevity Podcast: Optimizing HealthSpan & MindSpan episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!